FIELD: biotechnology.
SUBSTANCE: invention relates to proteins of the biosynthesis of fungal luciferin. The invention discloses new enzymes of the biosynthesis of fungal luciferin and the nucleic acids encoding them, the use of proteins and nucleic acids in the biosynthesis of fungal luciferin.
EFFECT: disclosure of methods of obtaining luciferin and pre-luciferin from fungi in in vitro and in vivo systems, as well as the use of such substances as phosphors in various fields of science.
20 cl, 25 ex, 6 tbl, 9 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| LUCIFERIN BIOSYNTHESIS ENZYMES AND USE THEREOF | 2018 |
|
RU2730038C2 |
| TYPE III POLYKETIDE SYNTHASES AND USE THEREOF | 2020 |
|
RU2822532C2 |
| HISPIDIN SYNTHASES AND THEIR USE | 2020 |
|
RU2809367C2 |
| IMMUNOCYTOKINES BASED ON IL-15 AND IL-15Rα OF THE SUSHI DOMAIN | 2012 |
|
RU2763298C2 |
| MULTIMERIZING POLYPEPTIDES DERIVED FROM DOMAIN WITH ROLL-TYPE PENTONE BASE OF ADENOVIRUS | 2019 |
|
RU2820522C2 |
| HPV-SPECIFIC BINDING MOLECULES | 2018 |
|
RU2804664C2 |
| DOG ANTIBODIES WITH MODIFIED CH-CH SEQUENCES | 2014 |
|
RU2815059C2 |
| CD123-SPECIFIC CHIMERIC ANTIGENIC RECEPTORS FOR CANCER IMMUNOTHERAPY | 2015 |
|
RU2727290C2 |
| METHODS AND PRODUCTS FOR PRODUCING AND DELIVERING NUCLEIC ACIDS | 2015 |
|
RU2714404C2 |
| DOG ANTIBODIES WITH MODIFIED CH2-CH3 SEQUENCES | 2014 |
|
RU2801209C2 |
